Biogen Alzheimer’s drug moves to late stage trial
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for…
Novo Nordisk releases new high-dose Wegovy data
A Wegovy injection pen shown in Waterbury, Vermont, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images…
Novo Nordisk faces Ozempic generics in Canada
Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood…
Novo Nordisk CEO Mike Doustdar says Ozempic maker looking for deals
Novo Nordisk is looking for deals more than ever before, the CEO of the Danish drugmaker said in…
How Barrière aims to disrupt the supplement industry
The supplement industry has seen booming demand over the past few years as consumers increasingly focus on health…
CVS Health (CVS) earnings Q1 2026
A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24,…
FDA withdrew studies finding Covid, shingles vaccines were safe
The FDA blocked the publication of several studies supporting the safety of vaccines against Covid and shingles in…
FDA Commissioner Marty Makary defends Replimune drug approval decision
U.S. Food and Drug Administration Commissioner Marty Makary defended himself in a CNBC interview aired Tuesday after months…
UnitedHealth, Cigna, Humana earnings show insurers are recovering
Piotr Swat | SOPA Images | Lightrocket | Getty Images Major health insurers appear to be off to…
Pfizer (PFE) earnings Q1 2026
Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press |…
Novo Nordisk Wegovy pill beating Eli Lilly Foundayo early
Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images When the Wegovy pill launched in…
FDA proposes excluding Novo, Lilly GLP-1s from compounding list
The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009. Jason Reed…